We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




EMR Market in Europe Expected to Double

By HospiMedica International staff writers
Posted on 30 Oct 2012
Europe may provide the next opportunity for electronic medical record (EMR) software companies as healthcare systems update their systems. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

EMRs have been an established market in some countries for over 10 years in some countries such as the Nordic countries, while in others, such as the United Kingdom, Germany, France, and Spain, EMR adoption is on course with the United States; but even in those countries where the EMR market growth has been successful, systems are becoming outdated and need to be upgraded. A major obstacle to further adaptation is due to differences in legislation, healthcare organizational structure, and language barriers that have thwarting EMR companies attempting to develop a universal system.

These implementation issues have kept the overall European market revenue growth at a modest rate of 3%. But according to the Kalorama Information report, the growth rate is expected to double in the coming years. Several factors will drive this growth, including a growing elderly population, rapid development of medical technology, and cost. This is accompanied by is a strong drive to reduce avoidable medical errors, thus improving overall quality of care and facilitating the sharing of patient information.

Another factor driving EMR adoption is the need to meet the legal requirements mandated by the health governing bodies within individual countries to improve security and privacy provisions in order to comply with government-funded policies and to increase organizational performance. On the other hand, there are also challenges and barriers to the adoption of EMRs in Europe, including lack of funds, time, and cooperation of users, complexity of the systems, and evaluation of need. The European EMR market reached revenues of USD 6.8 billion in 2012.

“Many of the EMR systems in various countries are outdated and not very efficient, creating an opportunity for new competitors,” said Kalorama analyst Mary Ann Crandall. “Most EMR systems used in Europe are of local design but several companies are making inroads in this area.”

Related Links:

Kalorama Information




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Pedicle Screw Platform
CREO DLX Stabilization System
New
Warming Cabinet
EC1850BL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.